Jérôme Becquart

731 total citations
16 papers, 597 citations indexed

About

Jérôme Becquart is a scholar working on Molecular Biology, Organic Chemistry and Materials Chemistry. According to data from OpenAlex, Jérôme Becquart has authored 16 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Materials Chemistry. Recurrent topics in Jérôme Becquart's work include Enzyme Structure and Function (5 papers), Protein Structure and Dynamics (3 papers) and Protein purification and stability (3 papers). Jérôme Becquart is often cited by papers focused on Enzyme Structure and Function (5 papers), Protein Structure and Dynamics (3 papers) and Protein purification and stability (3 papers). Jérôme Becquart collaborates with scholars based in France and United States. Jérôme Becquart's co-authors include Nadine Fromage, J.P. Guilloteau, A. Ducruix, S. Maignan, B. Arnoux, G. Jung, J F Mayaux, R. Fleer, P Yeh and Patrice Denèfle and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Biotechnology.

In The Last Decade

Jérôme Becquart

16 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jérôme Becquart France 10 484 112 69 67 62 16 597
Malaya Bhattacharya United States 14 348 0.7× 169 1.5× 49 0.7× 46 0.7× 54 0.9× 31 598
James Wells United States 5 646 1.3× 111 1.0× 130 1.9× 83 1.2× 88 1.4× 6 815
Kerstin K. Leuther United States 13 928 1.9× 84 0.8× 77 1.1× 37 0.6× 130 2.1× 19 1.2k
Simon Vogel Germany 11 391 0.8× 67 0.6× 68 1.0× 102 1.5× 63 1.0× 17 600
Diane L. Hevehan United States 5 341 0.7× 62 0.6× 79 1.1× 37 0.6× 73 1.2× 6 465
Takanori Yasukochi Japan 15 315 0.7× 34 0.3× 104 1.5× 53 0.8× 63 1.0× 27 600
Hang‐Cheol Shin South Korea 12 473 1.0× 48 0.4× 115 1.7× 41 0.6× 46 0.7× 30 666
Rosemarie Raffen United States 11 774 1.6× 113 1.0× 162 2.3× 31 0.5× 72 1.2× 12 949
Arun K. Datta United States 14 623 1.3× 72 0.6× 50 0.7× 72 1.1× 58 0.9× 28 795
Akira Hitoi Japan 11 498 1.0× 69 0.6× 25 0.4× 69 1.0× 41 0.7× 13 647

Countries citing papers authored by Jérôme Becquart

Since Specialization
Citations

This map shows the geographic impact of Jérôme Becquart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Becquart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Becquart more than expected).

Fields of papers citing papers by Jérôme Becquart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Becquart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Becquart. The network helps show where Jérôme Becquart may publish in the future.

Co-authorship network of co-authors of Jérôme Becquart

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Becquart. A scholar is included among the top collaborators of Jérôme Becquart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Becquart. Jérôme Becquart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Aoudjehane, Lynda, Pierre‐Yves Boëlle, François Paye, et al.. (2016). Development of an in vitro model to test antifibrotic drugs on primary human liver myofibroblasts. Laboratory Investigation. 96(6). 672–679. 10 indexed citations
2.
Fournier, Alain, et al.. (2000). Microbiological High Throughput Screening: An Opportunity for the Lead Discovery Process. SLAS DISCOVERY. 5(1). 13–21. 7 indexed citations
3.
Guilloteau, J.P., Nadine Fromage, Madeleine Riès‐Kautt, et al.. (1996). Purification, stabilization, and crystallization of a modular protein: Grb2. Proteins Structure Function and Bioinformatics. 25(1). 112–119. 9 indexed citations
4.
Guilloteau, J.P., Nadine Fromage, Madeleine Riès‐Kautt, et al.. (1996). Purification, stabilization, and crystallization of a modular protein: Grb2. Proteins Structure Function and Bioinformatics. 25(1). 112–119. 19 indexed citations
5.
Maignan, S., J.P. Guilloteau, Nadine Fromage, et al.. (1995). Crystal Structure of the Mammalian Grb2 Adaptor. Science. 268(5208). 291–293. 169 indexed citations
6.
Guitton, Jean‐Dominique, Nadine Fromage, Yves Lelièvre, et al.. (1995). Constrained analogs of KCVFM with improved inhibitory properties against farnesyl transferase. Bioorganic & Medicinal Chemistry Letters. 5(16). 1779–1784. 23 indexed citations
7.
Byk, Gérardo, Marc Duchesne, Fabienne Parker, et al.. (1995). Local constrained shifty pseudopeptides inhibitors of rasfarnesyl transferase. Bioorganic & Medicinal Chemistry Letters. 5(22). 2677–2682. 7 indexed citations
8.
Clerc, François, et al.. (1994). Primary structure control of recombinant proteins using high-performance liquid chromatography, mass spectrometry and microsequencing. Journal of Chromatography B Biomedical Sciences and Applications. 662(2). 245–259. 6 indexed citations
9.
Yeh, P, D Landais, Marc Lemaître, et al.. (1992). Design of yeast-secreted albumin derivatives for human therapy: biological and antiviral properties of a serum albumin-CD4 genetic conjugate.. Proceedings of the National Academy of Sciences. 89(5). 1904–1908. 93 indexed citations
10.
Fleer, R., P Yeh, Alain Fournier, et al.. (1991). Stable Multicopy Vectors for High–Level Secretion of Recombinant Human Serum Albumin by Kluyveromyces Yeasts. Bio/Technology. 9(10). 968–975. 116 indexed citations
11.
Neuman, A., et al.. (1989). Structures de trois derivés de la benzo[f]flavone: fluoro-4' benzo[f]flavone, méthoxy-4' benzo[f]flavone, hydroxy-5 benzo[f]flavone. Acta Crystallographica Section C Crystal Structure Communications. 45(12). 1966–1970. 4 indexed citations
12.
Jung, G., Patrice Denèfle, Jérôme Becquart, & J F Mayaux. (1988). High-cell density fermentation studies of recombinant Escherichia coli strains expressing human interleukin-1β. Annales de l Institut Pasteur Microbiologie. 139(1). 129–146. 66 indexed citations
13.
Latta, Martine, Michael Knapp, Paolo Sarmientos, et al.. (1987). Synthesis and Purification of Mature Human Serum Albumin from E. Coli. Nature Biotechnology. 5(12). 1309–1314. 38 indexed citations
14.
Neuman, Alain, et al.. (1985). Structure cristalline du 2-acétamido-1,3,6-tri-O-acétyl-2-désoxy-4-O-(2,3,4,6-tétra-O-acétyl-α-l-idopyranosyl)-α-d-glucopyranose. Carbohydrate Research. 139. 23–34. 6 indexed citations
15.
Caron, Michel, et al.. (1982). Ultraviolet difference spectroscopy study of peanut lectin binding to mono- and disaccharides. Biochimica et Biophysica Acta (BBA) - General Subjects. 717(3). 432–438. 7 indexed citations
16.
Becquart, Jérôme, et al.. (1982). Structure cristalline d'une deuxième forme de mélézitose monohydrate. Effet de l'environnement sur la géométrie d'un oligosaccharide. Carbohydrate Research. 111(1). 9–21. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026